Background: The categories of recognized transferable quinolone resistance determinants have been increasing sharply. The rapid horizontal transfer of these quinolone resistance genes has caused concern since they bring new dissemination possibilities for quinolone resistance.
Introduction
Escherichia coli is one of the most commonly isolated microorganisms in clinical specimens. As a treatment alternative, fluoroquinolones have become some of the most frequently prescribed antimicrobials worldwide because of their broadspectrum antimicrobial activity. In parallel with the extensive consumption of fluoroquinolones in clinics, the rapid dissemination of fluoroquinolone-resistant E. coli isolates has become a major problem in infection control and treatment worldwide. Originally, quinolone resistance was attributed to mutations of the chromosomal genes encoding DNA gyrase and/or topoisomerase IV or the mutation of genes regulating the expression of efflux pumps and decreased expression of outer membrane porins. 1, 2 However, since a target protection plasmid-mediated quinolone resistance mechanism was described in Klebsiella pneumoniae isolates in 1998, 3 the categories of recognized transferable quinolone resistance determinants have been increasing and the dissemination of these determinants has been expanding sharply in the last decade. To date, at least five major groups of qnr determinant, including qnrA, qnrB, qnrC, qnrD and qnrS, have been reported. 4 -6 Recently, two new transferable quinolone resistance mechanisms, aac-(6 0 )-Ib-cr, which encodes an aminoglycoside acetyltransferase variant that modifies ciprofloxacin, and qepA, which encodes an efflux pump belonging to the major facilitator subfamily, have also been described. 7, 8 Since the introduction of these new transferable quinolone resistance determinants, the horizontal transfer of these genes has attracted serious concern. Many epidemiological surveys on transferable quinolone resistance determinants in E. coli have been conducted in recent years, including several reports from China, but most of these studies focused on isolates with specific resistance phenotypes, such as resistance to extended-spectrum b-lactams, the aminoglycoside resistance phenotype of rmtB, or included only limited numbers of E. coli isolates. 9, 10 Few reports are available that describe the distribution pattern of transferable quinolone resistance determinants in China (a large fluoroquinolone producing and consuming country) through a good collection of recent clinical E. coli isolates.
In this study, we determined the prevalence of qnrA, qnrB, qnrS, aac-(6 0 )-Ib-cr and qepA in 579 E. coli isolates collected from nine Chinese hospitals. The isolates harbouring transferable quinolone resistance determinants were further characterized by PFGE, phylogenetic analysis and sequence analysis of the quinolone resistance determining regions (QRDRs) of gyrA and parC.
Materials and methods

Bacterial strains
In total, 579 E. coli isolates recovered from individual inpatient clinical specimens, including urine (n¼363), blood (n¼126) and other categories (n ¼90), were collected from nine tertiary hospitals in 2008. A single isolate was included from each patient. All urinary isolates were recovered from urine specimens in which the total viable aerobic count was .10 5 cfu/mL. All 579 isolates were screened by PCR amplification for the transferable quinolone resistance determinants qnrA, qnrB, qnrS, aac-(6 0 )-Ib and qepA as previously described. 11 -13 All PCR products positive for aac-(6 0 )-Ib were digested with BtsCI (New England Biolabs, Beijing, China) to identify aac-(6 0 )-Ib-cr, which lacks the BtsCI restriction site, while the wild-type aac-(6 0 )-Ib PCR product yielded 210 bp and 272 bp fragments after digestion. 13 Salmonella enterica isolates carrying qnrA, qnrB6, qnrS2 and aac-(6 0 )-Ib-cr from a previous study 14 and an E. coli C600-derivative harbouring qepA that was confirmed by sequencing were used as control organisms. The transmission capacity of qnr alleles aac-(6 0 )-Ib-cr and qepA was examined by conjugation test as previously described 15 and azide-resistant (MIC .300 mg/L) E. coli JM109 was used as the recipient. All E. coli isolates harbouring transferable quinolone resistance determinants were further reconfirmed by the API 20E test (BioMérieux, Beijing, China) and stored in brain heart infusion broth with 50% glycerol at -708C for further study.
Antimicrobial susceptibility testing
The MICs of amikacin, cefotaxime, ciprofloxacin and imipenem were measured using agar dilution for all 579 E. coli isolates. For E. coli isolates containing transferable quinolone resistance determinants, MICs of 12 antimicrobials (amikacin, cefepime, cefoxitin, ceftazidime, ceftazidime/ clavulanic acid, cefotaxime, cefotaxime/clavulanic acid, imipenem, nalidixic acid, ciprofloxacin, levofloxacin and gentamicin) were determined via broth dilution. All susceptibility results were interpreted according to the CLSI interpretive standards. 16 Isolates showing a 8-fold concentration decrease in MIC of either ceftazidime or cefotaxime tested in combination with clavulanic acid versus its MIC tested alone were considered as producing extended-spectrum b-lactamase (ESBL). 16 All ESBLproducing isolates were counted as resistant to cefepime, ceftazidime and cefotaxime as recommended by the CLSI. 16 E. coli ATCC 25922, E. coli ATCC 35218 and K. pneumoniae ATCC 700603 were used as quality control organisms in antimicrobial susceptibility experiments.
Phylogenetic analysis
Phylogenetic analysis of E. coli isolates containing transferable quinolone resistance determinants was determined through the presence or absence of chuA, yjaA and TspE4.C2 as previously described. 17 
PFGE
E. coli isolates containing transferable quinolone resistance determinants were analysed by PFGE to determine DNA fingerprinting profiles resulting from digestion by restriction enzyme XbaI (New England Biolabs, Beijing) according to the procedures developed by the United States Centers for Disease Control and Prevention (US CDC) PulseNet program. 18 The interpretation of the PFGE patterns was performed with BioNumerics software (Applied Maths, St-Martens-Latern, Belgium) using the Dice Similarity coefficient. The tree indicating relative genetic similarity was constructed on the basis of the unweighted pair group method of averages (UPGMA), position tolerance of 1%. Clusters were defined as DNA patterns sharing 70% similarity (C1, C2, C3 and so on). Similarity that differed by ,5% was considered to represent subtypes within the main group.
PCR amplification and DNA sequence analysis
The QRDRs of gyrA and parC in E. coli isolates containing transferable quinolone resistance determinants were amplified by PCR as described previously. 19 PCR products of qnr, aac-(6 0 )-Ib-cr and qepA were prepared following the screening methods as described above. All purified PCR products were sequenced and the sequences obtained were analysed by Sequencher 4.6 software (Gene Codes Corporation, Ann Arbor, MI, USA). The predicted amino acid sequences of GyrA and ParC were analysed for amino acid changes by comparison with wild-type GyrA (GenBank accession number NP_416734) and ParC (GenBank accession number NP_417491) of E. coli K-12 (GenBank accession number NC_000913). The qnrB and qnrS allele numbers were designated based on the qnr gene nomenclature. 4 
Results
Antimicrobial susceptibility of E. coli isolates
All 579 E. coli isolates were susceptible to imipenem. Resistance to ciprofloxacin was the most common (91.4%, 529/579) followed by cefotaxime (54.6%, 316/579) and amikacin (13.1%, 76/579). Out of 363 isolates from urine samples, 329, 175 and 34 isolates were resistant to ciprofloxacin, cefotaxime and amikacin, respectively. Out of 126 blood isolates, 119, 78 and 34 isolates were resistant to these three drugs, respectively.
Transferable quinolone resistance determinant screening
After PCR screening and sequence analysis, transferable quinolone resistance determinants were identified in 74 out of 579 E. coli isolates (12.8%). aac-(6 0 )-Ib-cr, qepA, qnrS, qnrB4 and qnrB6 were detected in 41, 28, 7, 3 and 1 isolates, respectively. Both aac-(6 0 )-Ib-cr and qepA were found in three E. coli isolates. In one each of three E. coli isolates containing aac-(6 0 )-Ib-cr, qnrB4, qnrB6 or qnrS1 was detected. The distribution of these 74 isolates in nine hospitals and the characteristics of these isolates are shown in Figure 1 .
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The antimicrobial resistance profiles differed between isolates containing different categories of transferable quinolone resistance determinant. Among 35 isolates containing aac-(6 0 )-Ib-cr alone, eight isolates were resistant to three tested quinolones, three extended-spectrum cephalosporins and gentamicin; another eight isolates were additionally resistant to cefoxitin. Five isolates were susceptible to all tested non-quinolone antimicrobials. Out of 25 isolates containing qepA alone, six isolates were resistant to cefoxitin, the three tested extended-spectrum cephalosporins, three quinolones and gentamicin, and another four isolates were additionally resistant to amikacin. Of these 25 isolates, 23 isolates were highly resistant to ciprofloxacin (MIC 512 mg/L). However, three out of six isolates containing qnrS1 alone were susceptible to all tested antimicrobials and another two isolates were resistant to nalidixic acid and the three extended-spectrum cephalosporins (Figure 1) .
The MICs of nalidixic acid, ciprofloxacin and levofloxacin for the recipient E. coli JM109 were 4, 0.0075 and 0.0075 mg/L, respectively. In transconjugants containing aac-(6 0 )-Ib-cr, the MIC of ciprofloxacin increased 4-to 64-fold, the MIC of nalidixic acid increased 2-to 16-fold and the MIC of levofloxacin increased 0-to 8-fold. In transconjugants containing qnrB4 or qnrS1, the MIC of nalidixic acid increased 4-fold and the MICs of ciprofloxacin and levofloxacin increased 8-to 16-fold. In transconjugants containing qepA, the MIC of nalidixic acid increased 0-to 4-fold, the MIC of ciprofloxacin increased 2-to 16-fold and the MIC of levofloxacin increased 0-to 16-fold.
Identification of mutations in GyrA and ParC
Point mutations in QRDRs of GyrA and ParC were identified in 69 out of 74 E. coli isolates containing transferable quinolone resistance determinants. Three point mutations were found in 56 isolates: GyrA (S83L, D87N) and ParC (S80I) in 51 isolates, GyrA (S83L, D87N) and ParC (S80R) in 2 isolates, GyrA (S83L, D87Y) and ParC (S80I) in 2 isolates, and GyrA (S83I, D87N) and ParC (S80I) in 1 isolate. Four point mutations were found in 10 isolates: GyrA (S83L, D87N) and ParC (S80I, E84V) in 5 isolates, GyrA (S83L, D87N) and ParC (S80I, E84G) in 2 isolates, GyrA (S83L, D87Y) and ParC (S80I, E84G) in 2 isolates, GyrA (S83L, D87Y) and ParC (S80I, E84V) in 1 isolate. A single mutation in GyrA was identified in three isolates: GyrA (S83I) in one isolate, GyrA (S83L) in one isolate and GyrA (S83T) in one isolate. No GyrA and ParC mutations were identified in five E. coli isolates containing qnrS1. All isolates containing qepA were found to have accumulated three or four point mutations in the QRDRs of GyrA and ParC.
Phylogenetic typing
Of 35 isolates containing aac-(6 0 )-Ib-cr alone, 17 isolates belonged to phylogenetic group A, 16 isolates belonged to group D and the remaining 2 isolates belonged to groups B1 and B2, respectively. However, 22 out of 25 isolates containing qepA alone were from group D, 2 isolates from group B2 and 1 isolate from group A. Of the eight isolates containing qnr alone, three isolates containing qnrS1 and one isolate containing qnrB4 belonged to group A, two isolates containing qnrS1 belonged to group D, one qnrB4-containing isolate and one qnrS1-containing isolate belonged to groups B1 and B2, respectively. Of six isolates (Figure 1 ).
PFGE
In total, 69 PFGE patterns and 19 clusters were identified among 74 E. coli isolates containing transferable quinolone resistance determinants. More than one isolate was found in three PFGE patterns. All isolates in clusters C1 and C3 contained qepA and were grouped into phylogenetic group D. Isolates in PFGE clusters C6, C8, C12, C16, C17 and C19 contained aac-(6 0 )-Ib-cr. Isolates in PFGE clusters C2, C4, C5, C7, C11 and C14 contained either aac-(6 0 )-Ib-cr or qepA. Resistance mechanisms qnr or aac-(6 0 )-Ib-cr were identified in PFGE clusters C9, C13, C15 and C18. Isolates from seven clusters (C1, C2, C3, C4, C6, C7 and C19) belonged to phylogenetic group D and isolates from five clusters (C9, C15, C16, C17 and C18) belonged to phylogenetic group A.
Discussion
In this study, .90% E. coli isolates were resistant to fluoroquinolones, which was much higher than in other studies of clinical E. coli isolates in China. 20, 21 The high ratio of fluoroquinoloneresistant isolates in this study might result from the following factors. Firstly, all isolates in this study were from inpatients of tertiary hospitals where large amounts of antimicrobials were used, especially fluoroquinolones. Secondly, since fluoroquinolone-resistant E. coli isolates were usually multidrug resistant as previous studies have reported, the application of other antimicrobials in clinics could also facilitate the selection of these isolates. As .90% of E. coli isolates were resistant to fluoroquinolones, suspension of this category of antimicrobials should be considered for E. coli infection treatment in these hospitals.
The wide PFGE profile variation of these 74 isolates demonstrated extensive genetic heterogeneity among E. coli isolates containing transferable quinolone resistance determinants, which also proves the high transmission capacity of these transferable quinolone resistance determinants. Besides in E. coli, these transferable quinolone resistance determinants have also been documented in clinical and environmental Aeromonas species isolates and other Enterobacteriaceae isolates, including Enterobacter cloacae, K. pneumoniae and S. enterica in the past decade.
9,22 -24 Why these mechanisms have transferred so fast and widely is not yet clear, but the high resistance ratio of these E. coli hosts to cephalosporins, amikacin and gentamicin, which are the common antimicrobials used in clinics, should provide them with a selective advantage over other isolates. Additionally, these transferable quinolone resistance determinants usually reside in large plasmids that can be transmitted to other microorganisms through conjugation, which has further contributed to their dissemination capacity. 10 Since the transmission of these determinants is dependent on plasmids, the genetic characteristics of these plasmids should be studied in detail to uncover the transmission route of these mechanisms.
In this study, 67 out of 68 E. coli isolates containing qepA or aac-(6 0 )-Ib-cr were resistant to ciprofloxacin and 65 isolates harboured mutations in both GyrA and ParC (Figure 1) , while five out of six isolates containing qnrS1 alone did not possess mutations in the QRDRs of GyrA and ParC (Figure 1) . Previous studies have shown that transferable quinolone resistance determinants can allow bacteria to survive in the presence of quinolones and substantially enhance the number of resistant mutants that can be selected from the population. 25, 26 But the accurate contribution of these transferable determinants in the generation of QRDR point mutations has not been clearly documented. It might be interesting to carry out a comparison study of these transferable quinolone resistance determinants in a defined chromosomal background.
Previous studies have reported that the prevalence of qepA in E. coli was ,1%, 27,28 but in our study, the prevalence of qepA in E. coli isolates was .4%. This difference might result from the composition of the E. coli population selected to screen for qepA. In this study, .90% of E. coli isolates were resistant to ciprofloxacin. In addition, 25 out of 28 qepA carriers showed ciprofloxacin MICs of 512 mg/L and all 28 isolates also harboured QRDR mutations in both GyrA and ParC. For qepA transconjugants, MIC increases to various quinolones were observed, but none of the transconjugants was resistant to fluoroquinolones. This high MIC for the original E. coli isolates might result from the multiplication effect of QRDR mutations and qepA as it has been shown previously that QepA confers decreased susceptibility to hydrophilic fluoroquinolones (e.g. norfloxacin, ciprofloxacin and enrofloxacin). 29 Whether high MICs of ciprofloxacin could be used as a qepA screening indicator needs to be studied further.
In this study, ciprofloxacin showed higher discriminatory power than nalidixic acid and levofloxacin as a screening indicator for transferable quinolone resistance determinants, as previously reported (Table 1) . 23 The difference might result from the structural differences of each quinolone and the substrate specificity of each transferable quinolone resistance determinant. Even for ciprofloxacin, different MIC values were identified for isolates with the same QRDR mutations and transferable quinolone resistance determinants. The reason might be variation in the expression of these transferable quinolone resistance determinants as shown in the MICs for transconjugants or the involvement of other mechanisms, such as efflux pumps or outer membrane proteins. 30, 31 Additionally in this study, five out of six isolates containing qnrS1 had not accumulated mutations in the QRDRs of GyrA and ParC and were phenotypically not resistant to ciprofloxacin. Because of their limited reduction in susceptibility, they might go undetected by routine susceptibility testing in the clinical microbiology laboratory.
Our data showed that transferable quinolone resistance determinants could be found in E. coli isolates either producing or not producing ESBLs. Since these mechanisms were first described in isolates producing ESBLs, 3 several studies have used ESBL production as a screening indicator for transferable quinolone resistance mechanisms, 32, 33 but in our study, 23 out of 74 isolates containing transferable quinolone resistance determinants were susceptible to extended-spectrum cephalosporins. These data demonstrated that ESBL production should not be used as a screening indicator for transferable quinolone resistance determinants. Even nalidixic acid should not be used as the indicator since isolates containing the transferable quinolone resistance determinants might be susceptible to nalidixic acid as in this study. Instead, a deceased susceptibility to ciprofloxacin (MIC 0.125 mg/L) should be applied when screening for 23 Studies have shown that phylogenetic groups B2 and D usually carry the greatest number of virulence factors. 17 A greater number of isolates in phylogenetic group B2 from human patients compared with the other phylogenetic groups has been reported. 34 However, in this study, qepA-containing isolates showed a unique phylogenetic group distribution, with an extremely low percentage of isolates in groups B1 (1/25), A (2/25) and B2 (3/25) , and a high percentage of phylogenetic group D (22/28) isolates. However, most E. coli isolates containing aac-(6 0 )-Ib-cr belonged to phylogenetic group A (18/41) or D (19/41). These results indicate that the acquisition of transferable quinolone resistance determinants might be a specific event in limited isolates, such as isolates in phylogenetic group A or D. Since isolates of phylogenetic group D are usually more pathogenic, the extra-intestinal virulence factors of those isolates containing transferable quinolone resistance determinants should be further characterized to clarify whether those isolates harbour common virulence factors or not.
In this study, .9% of E. coli isolates harboured transferable quinolone resistance determinants and the increasing prevalence of transferable quinolone resistance determinants together with increasing use of fluoroquinolones and other antimicrobials may have been an important driving force for selection and dissemination of quinolone-resistant isolates. Our data show that these factors created an opportunity for the emergence of highly quinolone-resistant clinical isolates that compromised therapeutic options. Since the transmission of transferable quinolone resistance determinants is not dependent on bacterial species, it is urgent to characterize and block their transmission routes and save quinolones. Our data may be useful for the development of risk management strategies to slow down the transmission of quinolone resistance mechanisms.
